Page 1 of Clinical Trials for "Cyclophosphamide", 1965 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Lenalidomide/Low-dose Dexamethasone in Combination With Continuous Oral Cyclophosphamide Compared to Lenalidomide/Low-dose Dexamethasone Combined With Single Cyclophosphamide Doses IV in Patients With Relapsed/Refractory Multiple Myeloma
Last Updated: March 26, 2010
Condition(s): Multiple Myeloma
2
Recruiting
In-vivo Regulatory T Cell Enhancement With Cyclophosphamide and Sirolimus With or Without Vidaza (Azacitidine) for Steroid-refractory Acute Graft-versus-host Disease
Last Updated: October 14, 2011
Condition(s): Graft Versus Host Disease
3
Recruiting
Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23)
Last Updated: January 30, 2012
Condition(s): Leukemia
4
Recruiting
Neoadjuvant Treatment of Docetaxel, Anthracycline and Cyclophosphamide (TAC) Versus Docetaxel and Cyclophosphamide (TC) in Triple-Negative or Her2 Positive Breast Cancer
Last Updated: March 22, 2012
Condition(s): Breast Cancer
5
Recruiting
Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Diseases
Last Updated: October 18, 2011
Condition(s): Bone Marrow Failure; Osteopetrosis; Fanconi Anemia; Severe Combined Immunodeficiency
6
Terminated
Trial to Evaluate Genomic Expression Profiles to Direct Preoperative Chemotherapy in Early Stage Breast Cancer
Last Updated: November 3, 2010
Condition(s): Early-Stage Breast Cancer
7
Completed
Clofarabine and Cyclophosphamide Combination in Acute Lymphoblastic Leukemia Patients
Last Updated: April 17, 2012
Condition(s): Burkitt's Lymphoma; Lymphoblastic Lymphoma; Acute Lymphoblastic Leukemia
8
Not yet recruiting
Pancreatic Tumor Cell Vaccine (GVAX), Low Dose Cyclophosphamide, Fractionated Stereotactic Body Radiation Therapy (SBRT), and FOLFIRINOX Chemotherapy in Patients With Resected Adenocarcinoma of the Pancreas
Last Updated: May 9, 2012
Condition(s): Pancreatic Cancer
9
Active, not recruiting
Panther: A Study Comparing Biweekly and Tailored EC-T Versus Three Weekly FEC-T in Breast Cancer Patients
Last Updated: February 27, 2012
Condition(s): Breast Cancer
10
Active, not recruiting
Letrozole Plus Oral Cyclophosphamide Plus/Minus Sorafenib as Primary Systemic Treatment in Breast Cancer Patients
Last Updated: August 6, 2009
Condition(s): Breast Cancer
11
Completed
TMC (Topotecan, Cyclophosphamide and Melphalan) for Multiple Myeloma
Last Updated: December 23, 2009
Condition(s): Myeloma
12
Not yet recruiting
Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT)
Last Updated: April 20, 2011
Condition(s): Acute Leukemias; Chronic Leukemias; Myelodysplastic Syndrome; Juvenile Myelomonocytic Leukemia
13
Recruiting
CpG 7909/Montanide ISA 720 With or Without Cyclophosphamide in Combination Either With NY-ESO-1-derived Peptides or the NY-ESO-1 Protein for NY-ESO-1-expressing Tumors
Last Updated: January 6, 2012
Condition(s): NY-ESO-1-expressing Tumors
14
Completed
A Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias.
Last Updated: June 10, 2011
Condition(s): Acute Lymphoblastic Leukemia; Acute Myelogenous Leukemia; Relapsed Leukemia
15
Active, not recruiting
Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide
Last Updated: December 13, 2011
Condition(s): Hematologic Diseases; Leukemia; Lymphoma; Myeloma
16
Recruiting
Study of Bortezomib in Combination With Cyclophosphamide and Rituximab
Last Updated: March 15, 2012
Condition(s): Mantle Cell Lymphoma; Lymphoma
17
Recruiting
Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed By Donor Bone Marrow Transplant, Cyclophosphamide, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Immunodeficiency or Noncancerous Inherited Disorders
Last Updated: January 23, 2012
Condition(s): Nonneoplastic Condition
18
Recruiting
Cancer Vaccines CRS-207 and GVAX Pancreas for Metastatic Pancreatic Adenocarcinoma
Last Updated: May 18, 2012
Condition(s): Pancreatic Cancer
19
Active, not recruiting
Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma
Last Updated: January 13, 2012
Condition(s): Mantle Cell Lymphoma
20
Active, not recruiting
Study of the Combination of VELCADE, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma
Last Updated: January 13, 2012
Condition(s): Diffuse Large B-Cell Lymphoma

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?intr=%22Cyclophosphamide%22

Page 1 of Clinical Trials for "Cyclophosphamide", 1965 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About